Sowell Financial Services LLC Editas Medicine, Inc. Transaction History

Sowell Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$31.29 - $56.64 $26,095 - $47,237	-834 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$39.71 - $90.58 $17,273 - $39,402	435 Added 109.02%	834 $29,000
Q4 2020 Jan 13, 2021	SELL	$27.07 - $84.35 $7,525 - $23,449	-278 Reduced 41.06%	399 $28,000
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $15,741 - $20,846	561 Added 483.62%	677 $19,000
Q1 2020 May 12, 2020	BUY	$14.88 - $32.78 $1,726 - $3,802	116 New	116 $2,000

250

57.1M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $92.1M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.